Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CCL11 antibody

CCL11 Reactivity: Mouse FACS Host: Mouse Monoclonal L402H11 unconjugated
Catalog No. ABIN7517588
  • Target See all CCL11 Antibodies
    CCL11 (Chemokine (C-C Motif) Ligand 11 (CCL11))
    Reactivity
    • 3
    • 2
    • 2
    • 1
    Mouse
    Host
    • 3
    Mouse
    Clonality
    • 3
    Monoclonal
    Conjugate
    • 3
    This CCL11 antibody is un-conjugated
    Application
    • 3
    • 2
    • 1
    Flow Cytometry (FACS)
    Purification
    Affinity purified.
    Clone
    L402H11
    Isotype
    IgG2a
    Top Product
    Discover our top product CCL11 Primary Antibody
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Concentration
    0.5 mg/mL
    Buffer
    phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C
    Storage Comment
    Upon receipt, store undiluted between 2°C and 8°C.
  • Target
    CCL11 (Chemokine (C-C Motif) Ligand 11 (CCL11))
    Alternative Name
    CCL11 (CCL11 Products)
    Synonyms
    SCYA11 antibody, Scya11 antibody, eotaxin antibody, Eotaxin antibody, C-C motif chemokine ligand 11 antibody, chemokine (C-C motif) ligand 11 antibody, CCL11 antibody, Ccl11 antibody
    Background
    CCL11 selectively recruits eosinophils through binding to the chemokine receptor CCR3 during allergic response. CCL11 production is upregulated in response to several proimflammatory cytokines, such as IL-4, IL-13, TNF-α, and IFN-α, produced by mast cells and Th2 lymphocytes. CCL11 has been reported to stimulate eosinophil release from bone marrow, resulting in an elevated level of circulating eosinophils.
    Pathways
    Regulation of Actin Filament Polymerization, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
You are here:
Support